June 11 — JD Health and Harbin Pharmaceutical Group signed a strategic cooperation agreement in China to collaborate on new-drug first launches, AI-driven precision recommendations, patient education and whole-course disease management. They will jointly promote a scientific nutrition approach of morning zinc and evening calcium and pursue a systematic upgrade from pediatric vitamin-mineral products to all-age bone-nutrition supplementation and therapeutic products.